Federal taxation of the drug industry and its effects on new drug development / Gary Guenther.
Electronic resources
Record details
- Physical Description: 1 online resource.
- Current Frequency: Updated irregularly
- Edition: [Library of Congress public edition].
- Publisher: [Washington, D.C.] : Congressional Research Service, 2019-
Content descriptions
| General Note: | The CRS report home page provides access to all versions published since 2018 in accordance with P.L. 115-141; earliest version dated 2009. |
| Bibliography, etc. Note: | Report includes bibliographical references. |
| Source of Description Note: | Description based on contents viewed on February 20, 2020; title from CRS report home page. |
Search for related items by subject
| Subject: | Drug development > United States. Pharmaceutical industry > Taxation > United States. |
Host Item Titles
| CRS reports (Library of Congress. Congressional Research Service) |
Search for related items by series
| LDR | 01957nai a2200421 i 4500 | ||
|---|---|---|---|
| 001 | 14381441 | ||
| 003 | CARDINAL | ||
| 005 | 20200227113848.0 | ||
| 006 | m o d f | ||
| 007 | cr mn||||||||| | ||
| 008 | 200227c20199999dcu x w o b f0 2eng c | ||
| 010 | . | ‡a2020231089 | |
| 035 | . | ‡a(OCoLC)1142100967 | |
| 040 | . | ‡aGPO ‡beng ‡erda ‡epn ‡cGPO | |
| 042 | . | ‡apcc | |
| 043 | . | ‡an-us--- | |
| 074 | . | ‡a0807-A-07 (online) | |
| 086 | 0 | . | ‡aLC 14.23:RL 31511/ |
| 100 | 1 | . | ‡aGuenther, Gary, ‡eauthor. |
| 245 | 1 | 0. | ‡aFederal taxation of the drug industry and its effects on new drug development / ‡cGary Guenther. |
| 250 | . | ‡a[Library of Congress public edition]. | |
| 264 | 1. | ‡a[Washington, D.C.] : ‡bCongressional Research Service, ‡c2019- | |
| 300 | . | ‡a1 online resource. | |
| 310 | . | ‡aUpdated irregularly | |
| 336 | . | ‡atext ‡btxt ‡2rdacontent | |
| 337 | . | ‡acomputer ‡bc ‡2rdamedia | |
| 338 | . | ‡aonline resource ‡bcr ‡2rdacarrier | |
| 490 | 1 | . | ‡aReport / Congressional Research Service ; ‡vRL31511 |
| 500 | . | ‡aThe CRS report home page provides access to all versions published since 2018 in accordance with P.L. 115-141; earliest version dated 2009. | |
| 504 | . | ‡aReport includes bibliographical references. | |
| 588 | . | ‡aDescription based on contents viewed on February 20, 2020; title from CRS report home page. | |
| 650 | 0. | ‡aDrug development ‡zUnited States. | |
| 650 | 0. | ‡aPharmaceutical industry ‡xTaxation ‡zUnited States. | |
| 710 | 2 | . | ‡aLibrary of Congress. ‡bCongressional Research Service, ‡eissuing body. ‡0(CARDINAL)142410 |
| 773 | 0 | 8. | ‡iContained in (work): ‡tCRS reports (Library of Congress. Congressional Research Service) ‡w(DLC) 2018231131 ‡w(OCoLC)1052784408 |
| 830 | 0. | ‡aCRS report ; ‡vRL31511. ‡0(CARDINAL)680247 | |
| 856 | 4 | 0. | ‡uhttps://purl.fdlp.gov/GPO/gpo132569 ‡7govdoc ‡9CARDINAL ‡yClick for online content. |
| 901 | . | ‡a14381441 ‡bgovdoc-script c2aea51b6ba88239b2793ad448463a63ed60fc95 1cce607ff11c4be0f7545d6fb553932b07bfc6b3 ‡c14381441 ‡tbiblio ‡selectronic | |
